|
|
 | | | |
- close
- close
- close
- close
Prana Biotechnology (PRAN) |
Benzinga
May 3
Comment
Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) is pleased to advise that its Share Purchase Plan (SPP) closed on Friday 26 April 2013 at 5.00 pm (EST) with applications received for 10,370,488 ordinary shares (New Shares).
Allotment of the New...
Wall Street Journal
Mar 30
Comment
Visual-effects studio Rhythm & Hues was acquired at auction by affiliate of competitor Prana Studios for $1.2 million in cash and the assumption of up to $17 million in debt.
Benzinga
Oct 1
Comment
Prana Biotechnology Limited (NASDAQ: PRAN) today announced that it has raised A$6.0 million (approx.) through a placement of 32,500,000 ordinary fully paid shares (equivalent to 3.25 million NASDAQ listed ADRs) at a price of A$0.185 per share. The...
Benzinga
Sep 19
Comment
Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:
Geokinetics
Shares of Geokinetics (NYSE: GOK), the Houston, TX provider of seismic data services, rose 31.98% Wednesday on 13 times...
Benzinga
Sep 12
Comment
Prana
Biotechnology (NASDAQ: PRAN) (ASX: PBT) today reported that it had
received a recommendation from the Data Safety Monitoring Board
(DSMB) that the IMAGINE trial for Alzheimer's disease should continue
as planned based on the initial review...
Benzinga
Aug 29
Comment
Prana Biotechnology Limited (NASDAQ: PRAN) announced today that its lead compound in development for Parkinson's disease (PD), PBT434, had progressed successfully though a series of preclinical development studies used to assess the suitability of...
StreetInsider.com
Aug 22
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Prana+Biotechnology+%28PRAN%29+Updates+on+PBT2+Phase+IIs/7678868.html for the full story.
Marketwire
Jun 13
Comment
MELBOURNE, AUSTRALIA -- (Marketwire) -- 06/13/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that an update on Prana's Phase 2 clinical trial in Huntington disease (HD) was presented at the HDSA annual National Convention held in
Marketwire
Jun 1
Comment
MELBOURNE, AUSTRALIA -- (Marketwire) -- 06/01/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that Executive Chairman, Geoffrey Kempler is scheduled to present a corporate update at upcoming healthcare conferences in Australia and
The Hindu Business Line
May 28
Comment
A Bangladeshi agro-food processing group, Programme for Rural Advancement Nationally (PRAN), will invest taka 10 crore (around Rs 6.80 core) to set up an agro-food processing unit in Tripura.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
